RPS6KB2 and lymphangioma: Within the PI3K/AKT/mTOR pathway, we identified ten genes that are differentially expressed in the blood samples of LM patients, including ribosomal protein S6 kinase B2 (RPS6KB2) and cyclin D3 (CCND3) (Fig 3B).